Skip to content
Study details
Enrolling now

Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders

Icahn School of Medicine at Mount Sinai
NCT IDNCT05554172ClinicalTrials.gov data as of Apr 2026
Target enrollment

30

Study length

about 3.9 years

Ages

14–22

Locations

1 site in NY

About this study

Researchers are testing if a non-invasive vagus nerve stimulation (taVNS) treatment leads to greater satisfaction, calorie consumption, and less eating disorder symptoms compared to sham stimulation. The trial will last 1418 days and involve approximately 30 participants.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Use Sham
  • 2.Use taVNS

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low8%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Secondary: Change in control using a Visual Analogue Scale (VAS), Change in disgust using a Visual Analogue Scale (VAS), Change in fear using a Visual Analogue Scale (VAS), Change in fullness using a Visual Analogue Scale (VAS), Change in hunger using a Visual Analogue Scale (VAS), Change in sickness using a Visual Analogue Scale (VAS), Change in the Gastroparesis Cardinal Symptom Index (GCSI), Change in thoughts of food using a Visual Analogue Scale (VAS)

Body systems

Psychiatry / Mental Health